Authors:
KAUFMAN FR
GERTNER JM
SLEEPER LA
DONFIELD SM
GOMPERTS E
KAUFMAN F
NELSON M
PEARSON S
HILGARTNER M
GERTNER J
GOLDBERG I
HOOTS WK
LOVELAND K
CANTINI M
WILLOUGHBY A
DONFIELD S
MAEDER MA
CONTANT C
KISKER CT
STEHBENS J
BALE J
COOL V
SIROIS P
SEXAUER C
HUSZTI H
HAWK S
ARKIN S
FORSTER A
SWINDELLS S
RICHARD S
PARMLEY R
MANGOS J
SCOTT A
HONECK L
LUSHER J
WARRIER I
BAIRDCOX K
HERSHEY MS
EYSTER ME
PATTISHALL E
NEAGLEY S
SHAPIRO A
HATCHER S
DAVIGNON G
RABWIN P
WICKLUND B
SPOOR M
Citation: Fr. Kaufman et al., GROWTH-HORMONE SECRETION IN HIV-POSITIVE VERSUS HIV-NEGATIVE HEMOPHILIC MALES WITH ABNORMAL GROWTH AND PUBERTAL DEVELOPMENT, Journal of acquired immune deficiency syndromes and human retrovirology, 15(2), 1997, pp. 137-144
Citation: J. Lusher et al., RECOMBINANT FVII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS, Thrombosis and haemostasis, 1997, pp. 664-664
Citation: J. Mendelson et al., INDEPENDENT EXPRESSION OF CD102 (ICAM-2) AND CD50 (ICAM-3), ON CD34 POSITIVE(+) HEMATOPOIETIC PROGENITORS, Experimental hematology, 24(9), 1996, pp. 291-291
Citation: J. Lusher et al., KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS, Blood, 88(10), 1996, pp. 1755-1755
Authors:
JASON J
SLEEPER LA
DONFIELD SM
MURPHY J
WARRIER I
ARKIN S
EVATT B
WILLOUGHBY A
WASSERMAN J
PEQUEGNAT W
GOMPERTS E
KAUFMAN F
NELSON M
SCHULTZE ME
PEARSON S
HILGARTNER M
GERTNER J
SCIACCA J
HOOTS WK
LOVELAND K
CANTINI M
CURRY C
MCKINLAY S
DONFIELD S
MAEDER MA
CONTANT C
KISKER CT
STEHBENS J
BALE J
COOL V
ANDES WA
SIROIS P
SEXAUER C
OLSON R
BOWMAN M
HAWK S
ALEDORT L
ARROYO M
HAIRE W
ERICKSON J
PARMLEY R
MANGOS J
SCOTT A
HONECK L
LUSHER J
BAIRDCOX K
HERSHEY MS
EYSTER E
PATTISHALL E
SCHAFER J
NEAGLEY CS
SHAPIRO A
HATCHER S
DAVIGNON G
MOLLEN P
WICKLUND B
SPOOR M
Citation: J. Jason et al., EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 471-476
Citation: J. Lusher et al., RECOMBINANT-FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS, Thrombosis and haemostasis, 73(6), 1995, pp. 1012-1012
Citation: S. Arkin et al., MODULATION OF ADHESION MOLECULE CD54 EXPRESSION ON CD34(+) HEMATOPOIETIC PROGENITORS, Experimental hematology, 23(7), 1995, pp. 588-596
Authors:
KRONER BL
GOEDERT JJ
BLATTNER WA
WILSON SE
CARRINGTON MN
MANN DL
OBRIEN SJ
WILLOUGHBY A
KESSEL W
DONFIELD SM
MCKINLAY SM
ALEDORT LM
ARKIN S
EYSTER ME
PATTISHALL EG
HILGARTNER MW
KONKLE B
WHITE GC
COHEN AR
BRAY GL
LUBAN N
KESSLER CM
RAGNI MV
LEDERMAN MM
LEISSINGER C
SIROIS P
MANCOJOHNSON M
DEMOERLOOSE P
MAHE A
HATZAKIS A
MANDALAKI T
SCHRAMM W
EICHINGER S
STINGL G
GOMPERTS ED
HOOTS WK
LOVELAND KA
KISKER CT
STEHBENS AA
CONTANT CF
HUSZTI H
SWINDELLS S
MANGOS J
WARRIER I
SHAPIRO AD
DAVIGNON GF
WICKLUND BM
WINKLER C
Citation: Bl. Kroner et al., CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS, AIDS, 9(3), 1995, pp. 275-280
Citation: Jm. Lusher et al., RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS, Pediatric research, 37(4), 1995, pp. 161-161
Citation: J. Mendelson et al., CD102 (ICAM-2) AND CD50 (ICAM-3), UNLIKE CD54 (ICAM-1) ARE CONSTITUTIVELY EXPRESSED ON HEMATOPOIETIC PROGENITORS, Blood, 86(10), 1995, pp. 2685-2685
Authors:
PIZZOLATO J
GREENBERG D
STREETER G
MANFREDI J
LACKNER C
ARKIN S
TENDLER C
Citation: J. Pizzolato et al., P53 STATUS IN AIDS LYMPHOMA CELL-LINES CORRELATES WITH SENSITIVITY TOCHEMOTHERAPY AND RADIATION-INDUCED APOPTOSIS, Blood, 86(10), 1995, pp. 2943-2943
Authors:
ARKIN S
LUSHER J
ABILDGAARD C
BOGDANOFF D
HURST D
Citation: S. Arkin et al., PATTERN OF BLEEDING EPISODES IN YOUNG HEMOPHILIA-A PATIENTS - A NATURAL-HISTORY OF RECOMBINANT FACTOR-VIII (RFVIII) TREATMENT OF PREVIOUSLYUNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 3444-3444
Authors:
JASON J
MURPHY J
SLEEPER LA
DONFIELD SM
WARRIER I
ARKIN S
EVATT B
GOMPERTS ED
Citation: J. Jason et al., DIFFERENTIAL-EFFECTS OF HIV-INFECTION ON T-HELPER(1) AND T-HELPER(2) LYMPHOCYTES OF HEMOPHILIC CHILDREN AND ADOLESCENTS, The FASEB journal, 8(4), 1994, pp. 10000494-10000494
Authors:
JASON J
MURPHY J
SLEEPER LA
DONFIELD SM
WARRIER I
ARKIN S
EVATT B
GOMPERTS ED
Citation: J. Jason et al., IMMUNE AND SEROLOGIC PROFILES OF HIV-INFECTED AND NONINFECTED HEMOPHILIC CHILDREN AND ADOLESCENTS, American journal of hematology, 46(1), 1994, pp. 29-35
Authors:
WARRIER I
LUSHER J
ARKIN S
ABILDGAARD C
TENGBORN L
HUTHKUEHNE A
HURST D
Citation: I. Warrier et al., CD4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A RECEIVING RFVIII (KOGENATE), Transfusion, 34(8), 1994, pp. 732-733
Authors:
LUSHER J
ARKIN S
ABILDGAARD C
INWOOD M
HILGARTNER M
HURST D
Citation: J. Lusher et al., INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE, Pediatric research, 35(4), 1994, pp. 10000165-10000165
Citation: J. Lusher et al., KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS, Blood, 84(10), 1994, pp. 10000239-10000239
Authors:
BRAY GL
GOMPERTS ED
COURTER S
GRUPPO R
GORDON EM
MANCOJOHNSON M
SHAPIRO A
SCHEIBEL E
WHITE G
LEE M
GORDON M
BERTALONE S
LIPTON R
HILGARTNER M
ARKIN S
GILL J
KIM H
SHURIN S
SANTIAGOBORRERO P
ARKEL YS
KULKARNI R
GREENWOOD MF
RITCHEY AK
WERNER E
HAIRE WD
KISKER T
NEUFELD E
EWENSTEIN B
DEBIASI R
LAURIAN Y
KREUZ W
RODEGHIERO F
INGERSLEV J
GAZENGEL C
DIMICHELE D
COOPER H
Citation: Gl. Bray et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Blood, 83(9), 1994, pp. 2428-2435
Authors:
MANNUCCI PM
BRETTLER DB
ALEDORT LM
LUSHER JM
ABILDGAARD CF
SCHWARTZ RS
HURST D
JOLLY K
HARRISON J
ADDIEGO JE
JEREB R
ARKIN S
ALEDORT LM
FOSTER A
SEREMETIS S
DASANI H
HARRISON J
HILGARTNER MW
BOARDS N
INWOOD MJ
CLEGG E
KASPER C
MOCKARY P
KRILL C
DERY A
MILLER E
LEVINE P
FORSBERG A
VALDEZ L
JACQUES S
PFAFFMAN L
WARRIOR I
BRACKMANN HH
GRINGERI A
SANTAGOSTINO E
SCHARRER I
LEE C
ALLRED RU
BOGDANOFF D
DONALDSON D
MACKENZIE MA
BAILEY P
DYLA S
PENNINGTON JE
ZACCARINI P
LEIGH P
NEUMANN R
FUKUI H
Citation: Pm. Mannucci et al., IMMUNE STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE AND SERONEGATIVE HEMOPHILIACS INFUSED FOR 3.5 YEARS WITH RECOMBINANT FACTOR-VIII, Blood, 83(7), 1994, pp. 1958-1962
Authors:
MILLER TT
CALDWELL G
KAYE JJ
ARKIN S
BURKE S
BRILL PW
Citation: Tt. Miller et al., MR-IMAGING OF DEFEROXAMINE-INDUCED BONE DYSPLASIA IN AN 8-YEAR-OLD FEMALE WITH THALASSEMIA MAJOR, Pediatric radiology, 23(7), 1993, pp. 523-524
Authors:
LUSHER JM
ARKIN S
ABILDGAARD CF
INWOOD M
ZIMMERMANN R
HILGARTNER M
HURST D
Citation: Jm. Lusher et al., INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATMENT PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE, Blood, 82(10), 1993, pp. 10000153-10000153